same drug delivery concept, page-2

Hi loom,
The autoinfusor system is for subcutaneous infusion and hence an invasive technology as it works with needles.
The microneedle approach is probably even preferable to this approach as it works on a smaller scale when it comes to injection.

Injectable drug delivery devices are an entirely different section of the drug delivering market and should not have any effect on OBJ's ongoings.

Unilife presents this to pharmaceutical companies for clinical trials, if anybody will go along and start testing be prepared to hear again from them in about 3 years time.